566 related articles for article (PubMed ID: 19438459)
1. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
[TBL] [Abstract][Full Text] [Related]
3. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT
Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312
[TBL] [Abstract][Full Text] [Related]
4. Absence of BRAF and HRAS mutations in eruptive Spitz naevi.
Gantner S; Wiesner T; Cerroni L; Lurkin I; Zwarthoff EC; Landthaler M; Hafner C
Br J Dermatol; 2011 Apr; 164(4):873-7. PubMed ID: 21418173
[TBL] [Abstract][Full Text] [Related]
5. Spitz melanoma is a distinct subset of spitzoid melanoma.
Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I
Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433
[TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of spitzoid tumours: A clinical study.
Hafiji J; Rytina E; Burrows NP
Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697
[TBL] [Abstract][Full Text] [Related]
8. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
[TBL] [Abstract][Full Text] [Related]
10. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.
van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA
Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217
[TBL] [Abstract][Full Text] [Related]
11. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
14. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
17. High BRAF mutation frequency does not characterize all melanocytic tumor types.
Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
[TBL] [Abstract][Full Text] [Related]
18. Understanding spitzoid tumours: new insights from molecular pathology.
Da Forno PD; Fletcher A; Pringle JH; Saldanha GS
Br J Dermatol; 2008 Jan; 158(1):4-14. PubMed ID: 17916202
[TBL] [Abstract][Full Text] [Related]
19. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
[TBL] [Abstract][Full Text] [Related]
20. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
